BIO.B

Bio-Rad Laboratories, Inc. Class B

364.15

USD

0.00

0.00%

Oct 23, 09:39 UTC -4

Closed

After-Market

368.07

+3.93

+1.08%

Bio-Rad Laboratories, Inc. Class B (BIO.B) Earnings

BIO.B Earnings Reports

Positive Surprise Ratio

BIO.B beat 30 of 43 last estimates.

70%

Next Report

Date of Next Report

Nov 04, 2026

Estimate for Q3 26 (Revenue/ EPS)

$656.45M

$2.24

Implied change from Q2 26 (Revenue/ EPS)

+0.84%

-14.50%

Implied change from Q3 25 (Revenue/ EPS)

+0.53%

-0.44%

Bio-Rad Laboratories, Inc. Class B earnings per share and revenue

On Aug 04, 2026, BIO.B reported earnings of 2.62 USD per share (EPS) for Q2 26, beating the estimate of 1.76 USD, resulting in a 48.43% surprise. Revenue reached 651.00 million, compared to an expected 630.23 million, with a 3.30% difference.

Looking ahead to Q3 26, 6 analysts forecast an EPS of 2.24 USD, with revenue projected to reach 656.45 million USD, implying an decrease of -14.50% EPS, and increase of 0.84% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Nurix Therapeutics, Inc. Common stock

Report Date

Oct 12, 2026 For Q3 26

Estimate

-$0.61

Actual

$4.73

Surprise

+871.74%

argenx SE - ADR

Report Date

Oct 22, 2026 For Q3 26

Estimate

$8.19

Actual

$7.80

Surprise

-4.84%

QIAGEN N.V.

Report Date

Oct 21, 2026 For Q3 26

Estimate

$0.63

Actual

$0.65

Surprise

+2.43%

Tiziana Life Sciences Ltd. Common Shares

Report Date

Oct 16, 2026 For Q2 26

Estimate

-$0.08

Actual

-$0.10

Surprise

-22.55%

FAQ

What were Bio-Rad Laboratories, Inc. Class B's earnings and revenue for the latest quarter Q2 2026?

For Q2 2026, Bio-Rad Laboratories, Inc. Class B reported EPS of $2.62, beating estimates by 48.43%, and revenue of $651.00M, 3.3% above expectations.

How did the market react to Bio-Rad Laboratories, Inc. Class B's Q2 2026 earnings?

The stock price moved -- --, changed from -- before the earnings release to -- the day after.

When is Bio-Rad Laboratories, Inc. Class B expected to report next?

The next earning report is scheduled for Nov 04, 2026.

What are the forecasts for Bio-Rad Laboratories, Inc. Class B's next earnings report?

Based on 6 analysts, Bio-Rad Laboratories, Inc. Class B is expected to report EPS of $2.24 and revenue of $656.45M for Q3 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.